Jay Shepard is listed as an executive officer and director on 8 SEC Form D filings by 5 issuers between Jan 2011 and Apr 2024: Aravive, Inc. (Houston, TX — biotechnology — 2014; $55M reported sold to 19 investors), NEXTWAVE PHARMACEUTICALS Inc (Cupertino, CA — pharmaceuticals — 2011; $27.2M reported sold to 11 investors), CESSATION THERAPEUTICS, INC. (Dallas, TX — biotechnology — 2022–2024; $5.75M reported sold to 31 investors), NeuroRecovery Technologies, Inc. (Dana Point, CA — other health care — 2016; $3.04M reported sold to 9 investors) and Bullet Biotechnology, Inc. (Redwood City, CA — biotechnology — 2013–2015; $1.14M reported sold to 34 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $92.2M sold in total.
Listed alongside Anthony Sun (2 shared filings), Diego Fonstad (2 shared filings), Edmon Jennings (2 shared filings), Francesco de Rubertis (2 shared filings), James Swartz (2 shared filings) and 35 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jay. Each name links to their own page.
1 of the issuers belongs to the sponsor group Aravive (2 issuers, $41.9M reported sold, 2011–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Aravive has 2 companies on file and $41.9M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Jay Shepard and found 7 differences: Form D filed 28 days after the first sale; 5 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.